ATE245980T1 - Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern - Google Patents
Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedernInfo
- Publication number
- ATE245980T1 ATE245980T1 AT96905942T AT96905942T ATE245980T1 AT E245980 T1 ATE245980 T1 AT E245980T1 AT 96905942 T AT96905942 T AT 96905942T AT 96905942 T AT96905942 T AT 96905942T AT E245980 T1 ATE245980 T1 AT E245980T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- pyruvate dehydrogenase
- limb ischemia
- dehydrogenase activator
- activator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9505082.9A GB9505082D0 (en) | 1995-03-14 | 1995-03-14 | Medicament |
PCT/GB1996/000555 WO1996028151A2 (en) | 1995-03-14 | 1996-03-11 | Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE245980T1 true ATE245980T1 (de) | 2003-08-15 |
Family
ID=10771147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96905942T ATE245980T1 (de) | 1995-03-14 | 1996-03-11 | Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0814801B1 (de) |
JP (1) | JPH11501653A (de) |
AT (1) | ATE245980T1 (de) |
AU (1) | AU4950296A (de) |
DE (1) | DE69629282T2 (de) |
GB (1) | GB9505082D0 (de) |
WO (1) | WO1996028151A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9804648D0 (en) * | 1998-03-06 | 1998-04-29 | Zeneca Ltd | Chemical compounds |
GB9805520D0 (en) | 1998-03-17 | 1998-05-13 | Zeneca Ltd | Chemical compounds |
GB9811427D0 (en) | 1998-05-29 | 1998-07-22 | Zeneca Ltd | Chemical compounds |
GB9811932D0 (en) * | 1998-06-04 | 1998-07-29 | Zeneca Ltd | Chemical compunds |
ATE399753T1 (de) | 1999-09-04 | 2008-07-15 | Astrazeneca Ab | Amide als pyruvatdehydrogenaseinhibitoren |
RU2255085C2 (ru) | 1999-09-04 | 2005-06-27 | Астразенека Аб | Замещенные производные n-фенил-2-гидрокси-2-метил-3,3,3-трифторпропанамида, повышающие активность пируватдегидрогеназы |
US6552225B1 (en) | 1999-09-04 | 2003-04-22 | Astrazeneca Ab | Chemical compounds |
-
1995
- 1995-03-14 GB GBGB9505082.9A patent/GB9505082D0/en active Pending
-
1996
- 1996-03-11 AU AU49502/96A patent/AU4950296A/en not_active Abandoned
- 1996-03-11 EP EP96905942A patent/EP0814801B1/de not_active Expired - Lifetime
- 1996-03-11 DE DE69629282T patent/DE69629282T2/de not_active Expired - Lifetime
- 1996-03-11 AT AT96905942T patent/ATE245980T1/de not_active IP Right Cessation
- 1996-03-11 WO PCT/GB1996/000555 patent/WO1996028151A2/en active IP Right Grant
- 1996-03-11 JP JP8527370A patent/JPH11501653A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU4950296A (en) | 1996-10-02 |
JPH11501653A (ja) | 1999-02-09 |
EP0814801B1 (de) | 2003-07-30 |
WO1996028151A3 (en) | 1997-01-23 |
WO1996028151A2 (en) | 1996-09-19 |
GB9505082D0 (en) | 1995-05-03 |
DE69629282D1 (de) | 2003-09-04 |
DE69629282T2 (de) | 2004-04-22 |
EP0814801A2 (de) | 1998-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60130023D1 (de) | Behandlung der nebenwirkungen von statinen | |
ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
AU1026599A (en) | Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same | |
ATE166534T1 (de) | Germicide wirkstoffkombinationen | |
TR200100610T2 (tr) | Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim | |
ATE299890T1 (de) | Inhibitoren von gamma-secretase | |
NO20003233L (no) | 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler | |
FI942423A0 (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
BR0311460A (pt) | Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente | |
MX9708452A (es) | Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma. | |
BG101138A (en) | The use of glyceryltriacetate for the treatment of onychomycosis | |
ATE245980T1 (de) | Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern | |
NO982721L (no) | Preserverende oppl°sning | |
DE69218816D1 (de) | N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt | |
ATE274513T1 (de) | Verbindungen und verfahren zur behandlung von schmerz | |
ES2163528T3 (es) | Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina. | |
TR199900153T2 (xx) | H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler. | |
DE69708109D1 (de) | Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben | |
HUP0002727A2 (hu) | Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával | |
DE69905144T2 (de) | N,N'-Diacylthiocystine | |
DE68919301T2 (de) | Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS. | |
NO955093L (no) | 14-substituerte marcfortiner og derivater som er anvendbare som antiparasittiske midler | |
TR199801887A2 (xx) | Bir Na+/H+ - de�i�tiricisi inhibit�r�. | |
ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |